Integra Lifesciences Holdings (IART) Asset Utilization Ratio (2010 - 2026)

Integra Lifesciences Holdings (IART) has 17 years of Asset Utilization Ratio data on file, last reported at 0.46 in Q1 2026.

• For the quarter ending Q1 2026, Asset Utilization Ratio rose 14.08% year-over-year to 0.46; the trailing twelve-month figure through Mar 2026 stood at 0.46 (up 14.08% YoY), and the FY2025 full-year result was 0.43, up 3.93% from the prior year.
• Asset Utilization Ratio climbed to 0.46 in Q1 2026, from 0.45 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.46 in Q1 2026 to a low of 0.38 in Q2 2024.
• A 5-year average of 0.41 and a median of 0.41 in 2023 frame the typical range for Asset Utilization Ratio.
• Across the five-year window, Asset Utilization Ratio fell 6.5% in 2024 and climbed 16.84% in 2025, its largest moves.
• Tracing IART's Asset Utilization Ratio over 5 years: stood at 0.4 in 2022, then gained by 1.27% to 0.41 in 2023, then dropped by 3.03% to 0.4 in 2024, then advanced by 13.51% to 0.45 in 2025, then gained by 1.53% to 0.46 in 2026.
• Business Quant data shows IART's Asset Utilization Ratio at 0.46 in Q1 2026, 0.45 in Q4 2025, and 0.45 in Q3 2025.